Atopic dermatitis (eczema) trials in Mexico

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

  Where

  Chihuahua City, Mexico City, Monterrey, Veracruz

  Age

  2 years to 11 years

  People

  450 worldwide

  Run by

  Pfizer

  See details and how to joinNCT06807281 · EU 2023-509124-18-00
• Phase 3Enrolling by invitation
  A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis

  Where

  Chihuahua City, Cuernavaca, Mexico City, Monterrey, Veracruz, Zapopan

  Age

  6 months to 18 years

  People

  338 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT05735483 · EU 2022-501478-21-00
• Phase 3Taking people
  A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

  Where

  Chihuahua City, Mexico City, Monterrey, Veracruz

  Age

  6 years to 11 years

  People

  150 worldwide

  Run by

  Pfizer

  See details and how to joinNCT06807268 · EU 2023-509121-51-00
• No phaseTaking people
  Effect of an Emollient Cream Containing a Milk Bioactive Peptide on Clinical Signs, Pruritus and Bacterial Colonization of Mild Atopic Dermatitis Skin Lesions in Pediatric Population

  Where

  Aguascalientes

  Age

  2 years to 12 years

  People

  20

  Run by

  Universidad Autónoma de Aguascalientes

  See details and how to joinNCT07259343